- Corporate Officers - B
- Bisaro Paul
Insider Trading History of Bisaro Paul
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bisaro Paul since 2015.
This trader's CIK number is 1237253.
At the time of last reporting, Bisaro Paul was the Officer of Keenova Therapeutics Plc. (stock ticker symbol NONE).
Also see all insider trading activities at Keenova Therapeutics Plc.
Note that in the past
Bisaro Paul also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Allergan Plc (AGN) by Bisaro Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | AGN | 0 | $0 | 70,000 | $17,297,000 | 37,727 | $0 |
| 2015 | AGN | 1,000 | $297,422 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Amneal Pharmaceuticals, Inc. (AMRX) by Bisaro Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | AMRX | 17,000 | $203,490 | 0 | $0 | 24,983 | $0 |
Yearly summary of insider trading at Keenova Therapeutics Plc (NONE) by Bisaro Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | NONE | 0 | $0 | 0 | $0 | 6,028 | $0 |
| 2023 | NONE | 5,000 | $42,330 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Therapeuticsmd, Inc. (TXMD) by Bisaro Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | TXMD | 0 | $0 | 0 | $0 | 1,984 | $0 |
| 2021 | TXMD | 50,000 | $39,500 | 0 | $0 | 96,864 | $0 |
| 2020 | TXMD | 50,000 | $56,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zoetis Inc. (ZTS) by Bisaro Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ZTS | 0 | $0 | 0 | $0 | 2,461 | $0 |
| 2024 | ZTS | 0 | $0 | 0 | $0 | 1,493 | $0 |
| 2023 | ZTS | 0 | $0 | 0 | $0 | 1,626 | $0 |
| 2022 | ZTS | 0 | $0 | 0 | $0 | 2,673 | $0 |
| 2021 | ZTS | 0 | $0 | 0 | $0 | 2,779 | $0 |
| 2020 | ZTS | 0 | $0 | 0 | $0 | 3,704 | $0 |
| 2019 | ZTS | 0 | $0 | 0 | $0 | 4,150 | $0 |
| 2018 | ZTS | 0 | $0 | 0 | $0 | 3,894 | $0 |
Insider trading activities at 5 companies by Bisaro Paul:
1. Allergan Plc (AGN)
2. Amneal Pharmaceuticals, Inc. (AMRX)
3. Keenova Therapeutics Plc (NONE)
4. Therapeuticsmd, Inc. (TXMD)
5. Zoetis Inc. (ZTS)
Table 1. Insider trading of Allergan Plc (AGN) by Bisaro Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-10-26 | AGN | Option Ex | 37,727 | .00 | 0 |
| 2017-03-02 | AGN | Sale | 70,000 | 247.10 | 17,297,000 |
| 2015-08-24 | AGN | Buy | 1,000 | 297.42 | 297,422 |
Table 2. Insider trading of Amneal Pharmaceuticals, Inc. (AMRX) by Bisaro Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-05-07 | AMRX | Option Ex | 24,983 | .00 | 0 |
| 2019-03-12 | AMRX | Buy | 17,000 | 11.97 | 203,490 |
Table 3. Insider trading of Keenova Therapeutics Plc (NONE) by Bisaro Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-01-01 | NONE | Option Ex | 3,014 | .00 | 0 |
| 2026-01-01 | NONE | Option Ex | 3,014 | .00 | 0 |
| 2023-03-14 | MNK | Buy | 5,000 | 8.47 | 42,330 |
Table 4. Insider trading of Therapeuticsmd, Inc. (TXMD) by Bisaro Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-08-18 | TXMD | Option Ex | 1,984 | .00 | 0 |
| 2021-08-16 | TXMD | Buy | 50,000 | .79 | 39,500 |
| 2021-08-10 | TXMD | Option Ex | 96,864 | .00 | 0 |
| 2020-06-04 | TXMD | Buy | 50,000 | 1.14 | 56,999 |
Table 5. Insider trading of Zoetis Inc. (ZTS) by Bisaro Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-08 | ZTS | Option Ex | 1,225 | .00 | 0 |
| 2025-02-06 | ZTS | Option Ex | 1,236 | .00 | 0 |
| 2024-02-08 | ZTS | Option Ex | 1,493 | .00 | 0 |
| 2023-02-11 | ZTS | Option Ex | 1,626 | .00 | 0 |
| 2022-02-12 | ZTS | Option Ex | 2,673 | .00 | 0 |
| 2021-02-13 | ZTS | Option Ex | 2,779 | .00 | 0 |
| 2020-02-14 | ZTS | Option Ex | 3,704 | .00 | 0 |
| 2019-02-19 | ZTS | Option Ex | 4,150 | .00 | 0 |
| 2018-05-01 | ZTS | Option Ex | 3,894 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bisaro Paul
(Officer of Keenova Therapeutics Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.